市場調查報告書
商品編碼
1182324
拋棄式醫療用感測器的全球市場預測(~2028年):各類型,各產品,各用途,各終端用戶,各地區的分析Disposable Medical Sensors Market Forecasts to 2028 - Global Analysis By Type, Product, Application, End User and By Geography |
全球拋棄式醫療用感測器的市場規模預測將從2022年的98億1,000萬美元,2028年達到195億9,000萬美元,在預測期間內以年複合成長率12.2%成長。
本報告提供全球拋棄式醫療用感測器市場相關調查分析,提供市場促進因素,阻礙因素,市場機會,COVID-19影響,各市場區隔的市場分析,競爭情形,主要企業的簡介等資訊。
According to Stratistics MRC, the Global Disposable Medical Sensors Market is accounted for $9.81 billion in 2022 and is expected to reach $19.59 billion by 2028 growing at a CAGR of 12.2% during the forecast period. Disposable medical sensors are mobile scanning tools that can be used for a number of therapeutic procedures, patient monitoring, and disease diagnosis. Through the conversion of the patient's various forms of stimulation, they are intended to detect and provide information in the form of electrical impulses. Making disposable medical sensors is mostly done to stop infections from transmitting from one patient to another. Disposable medical sensors that assess basic vital indicators including breathing rate, heart rate, blood oxygenation level, pulse rate, and temperature aid in continuous patient monitoring.
According to the Centers for Medicare & Medicaid Services in December 2021, the National health spending is projected to grow at an average annual rate of 5.4% for 2019-28 and to reach USD 6.2 trillion by 2028.
Market Dynamics:
Driver:
Rising concerns over hospital-acquired infections and contamination
Hospital-acquired infections (HAIs) have grown to be a significant problem for healthcare facilities throughout time. The widespread use of reusable medical equipment in hospitals, such as sphygmomanometer cuffs, thermometers, catheters, and stethoscopes, is a significant contributor to the rising occurrence of HAIs over the past two decades. The use of tainted medical equipment in hospitals is another factor in the increased incidence of HAIs, particularly in infants and other inpatients. In the end, this leads to high rates of morbidity and mortality, extended hospital stays, and higher healthcare and patient expenses. Therefore, the growth of the Disposable Medical Sensors market is growing.
Restraint:
Vulnerability of connected medical devices in term of data leakages
Due to the growing use of wireless medical devices worldwide, data security and privacy have grown to be key concerns for both consumers and healthcare practitioners. The market for Disposable Medical Sensors has obstacles due to the susceptibility of linked medical devices in terms of personal information leakages. These medical equipment are vulnerable to the risks of cyber attacks as IoT-based connected medical devices proliferate in the worldwide healthcare sector. Certain medical gadgets are vulnerable to hacking because of their connected nature. As a result, certain guidelines must be followed by makers of these medical equipment in order to protect patient privacy and security.
Opportunity:
New collaborations
Many collaborations have been launched in recent years to develop technologically advanced and user-friendly disposable medical sensors, which are projected to provide adequate chances to manufacturers functioning in the worldwide disposable medical sensors market. For instance, in May 2016, Qualcomm Inc. and Medtronic Plc. worked together to create a continuous glucose monitoring device for those with type 2 diabetes. Its goal was to make it possible to continuously monitor patients' blood sugar levels and so produce clinical data that might be used to support individualized medicine. To expand its production facilities in China, Medtronic Plc. partnered with the Chengdu municipal government.
Threat:
Lack of adequate reimbursement policies
Stringent regulatory requirements and a lack of proper reimbursement schemes for emerging technology are the main things that could slow the development of disposable medical sensors throughout the projection period. Lack of proper reimbursement is hampering the adoption of disposable medical sensors in various sectors.
COVID-19 Impact
The COVID-19 outbreak has increased demand for disposable medical device sensors on a global scale. This is mostly due to increasing infection prevention practices in healthcare settings as a result of the high virulence of the COVID-19 virus. People's increased awareness of simple and convenient solutions to obtain faster test results also contributes to rising demand. Consumers increasingly prefer remote healthcare services for the convenience and security of their own homes. For the early detection of SARS-CoV-2 during the present pandemic, researchers from all over the world have been working furiously to create novel biosensor-based techniques that are accurate and effective. Thus, during the COVID-19 the demand for the disposable medical devices increased thereby expected to show positive impact on the market.
The biosensor segment is expected to be the largest during the forecast period
The biosensor segment is estimated to have a lucrative growth, due to innovation and the requirement to perform faster diagnosis. A biosensor is a type of sensor that detects analytes. It collects biological components using a physiochemical detector. Signals emitted by the analyte are detected and quantified. Biosensors are typically coupled with electronics; signals are received by the sensor and presented on the gadget. Biosensors have use in both patient monitoring and diagnostics. The growing demand for quick and accurate diagnostic tests is opening up new potential for the development of biosensors.
The strip sensors segment is expected to have the highest CAGR during the forecast period
The strip sensors segment is anticipated to witness the fastest CAGR growth during the forecast period, due to reasons such as the use of strip-based products in numerous diagnostic applications such as illness testing, magnetic nanoparticles, and glucose monitoring Furthermore, the strip sensors is propelling due to rising demand and its use in diagnostic applications. The data are acquired more quickly when strip sensors are used, which is an additional advantage.
Region with highest share:
North America is projected to hold the largest market share during the forecast period owing to the introduction of new products and the concentration of numerous industry participants in this area. Favorable reimbursement regulations are expected to boost market expansion in North America even further. America include the increased prevalence of lifestyle-related health problems, accidents, and sports injuries. The rising demand for effective emergency care and the increasing use of mobile surgery centers are expected to drive the market.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the growing number of chronic illnesses and patient populations. The region's growth is also aided by medical tourism and improved healthcare infrastructure, adoption of new technologies in biomedical device sensors. Furthermore, the region is home to several major players in the global market for disposable medical sensors, which contributes to the region's market share.
Key players in the market
Some of the key players profiled in the Disposable Medical Sensors Market include GE Healthcare, Koninklijke Philips N.V., Smiths Medical, Analog Devices, Inc., STMicroelectronics, NXP Semiconductor, Sensirion AG, OmniVision Technologies, Medtronic, Mayo Clinic and Gentag, Honeywell International, Inc, Covidien, plc, Measurement Specialities, ACE Medical Devices, Abbott
Key Developments:
In March 2021, Abbott acquired FDA Emergency Use Authorization (EUA) for the non-prescription, over-the-counter use of their BinaxNOW COVID-19 AG self-test for the identification of COVID-19 infections.
In November 2020, GE Healthcare acquired Prismatic Sensors AB, a Swedish start-up that specializes in photon counting detectors. By investing in photon counting computed tomography, GE was able to increase its footprint in the biomedical sensor market (PCCT). Clinical performance in oncology, cardiology, neurology, and a range of other clinical CT applications could be improved using this technology.
In September 2020, Medtronic received FDA approval for its MiniMed 770G hybrid closed loop system. It consists of Guardian Sensor 3, the MiniMed Mobile app.
Types Covered:
Products Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: